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vitro supported the involvement of CD44 
in chemotaxis toward purifi ed HA, as 
CD44-null cells or null cells transfected 
to express a defective variant of CD44 
did not migrate.
Another important point is that 
Herrera and colleagues’ results8 were 
obtained in a ‘cell therapy’ protocol 
rather than in a protocol that uses irra-
diation to pre-engraft  cells throughout 
the recipient mouse. Irradiation is oft en 
used as a way to empty niches but might 
also encourage cell fusion. Whether cell 
fusion plays a part in the present results 
remains to be seen.
Precisely how deletion of CD44 
impairs the localization of exogenous 
MSCs (or whether endogenous MSCs 
behave in the same way) has yet to be 
established, and it will be interesting to 
see how eff ective the MSCs generated 
here are for therapy of acute renal failure 
in CD44-null mice, which respond dif-
ferently to damage. Nevertheless, expres-
sion by MSCs of CD44 as an integral 
receptor for HA is certainly involved, on 
the basis of the demonstration that trun-
cated CD44 is ineff ective at the binding 
of HA in vitro or at cell localization 
in vivo.
CD44 transcripts are subject to alter-
native splicing that contributes to the 
generation of a large family of protein 
isoforms and aff ects cell adhesion, but on 
the basis of the results here, a very basic 
cell mobility mechanism seems involved: 
CD44-null macrophages also have diffi  -
culty in migrating in vivo and attaching 
to vascular endothelium,9 and the rapid 
constitutive motility of certain invasive 
breast cancer cell lines is reported to 
require interaction of HA with cells, acti-
vation of ERK1/2, and the participation 
of both cell-surface CD44 and another 
HA receptor, Rhamm (CD168).10 So, it 
is possible that the CD44-null MSCs are 
disadvantaged in multiple ways — less 
able to move and less able to bind HA 
and matrix proteins.
One puzzling aspect of CD44-medi-
ated ‘targeting’ of damaged kidneys is 
that the injected MSCs were said not 
to localize to the renal medulla despite 
the constitutive presence there of most 
of the renal HA (Figure 1). Consider-
ing that HA is found in many organs, 
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Prevention of normal interactions between CD44 cell-surface receptors 
on cultured mesenchymal stem cells and hyaluronic acid in the 
renal interstitial matrix has been described as reducing the ability 
of these cells in vivo to localize to regions with acute tubular injury. 
Understanding processes such as this might one day help us to target 
exogenous cells to assist renal regeneration.
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Mesenchymal stem cells (MSCs), estab-
lished as being important in maintaining 
the niche occupied by hematopoietic stem 
cells,1 have been reported to be capable of 
much more. A spectrum of studies, more 
than can be cited in this Commentary, 
have suggested that exogenous bone mar-
row cells, purifi ed hematopoietic stem 
cells, or cultured MSCs may infiltrate 
mouse tissues and in particular circum-
stances aff ect the course of renal damage. 
Results from acute renal injury models, 
using glycerol,2 ischemia–reperfusion,3 
cisplatin,4 folic acid,5 and mercuric chlo-
ride,6 and genetically determined progres-
sive failure in mouse models of Alport’s 
syndrome (reviewed by Poulsom et al.7) 
have been reported, and hypotheses 
have been generated to explain how cells 
from outside the kidney might modulate 
regenerative processes via transdiff eren-
tiation, cell fusion, or cytokine release.
Herrera and col leagues8  (this 
issue) present a compelling case 
that interactions between CD44 and 
hyaluronans (hyaluronic acid (HA)) 
infl uence the way exogenous MSCs local-
ize to kidneys with acute renal failure. 
Th ese cells had been isolated from long 
bones of wild-type or CD44-null mice, 
and evidence of their MSC credentials 
included demonstration of their ability 
to show osteocyte or adipocyte pheno-
types in specifi c culture conditions.
Using a range of sensitive morphologi-
cal methods (Y-chromosome fl uores-
cence in situ hybridization, preloading 
with iron-dextran nanoparticles, and 
fl uorescent dye modifi cation) to assess 
the origin of nuclei and other cellular 
elements, Herrera et al.8 revealed that 
cells administered intravenously are 
soon found in peritubular capillaries, 
in the interstitial space, and even within 
damaged renal tubules, and this was 
accompanied by improvement in histo-
logical appearance and renal function as 
assessed by blood urea nitrogen levels.
So what’s new? Th e fresh insight pro-
vided by Herrera and colleagues8 derives 
from their evidence that the expression 
of CD44 on exogenous cells is important 
in helping the MSCs to localize to the 
damaged renal tissue in vivo. Wild-type 
MSCs with CD44 blocked by a neutral-
izing antibody were, as CD44-null cells, 
poor at reaching the damaged kidneys 
and did not improve blood urea nitro-
gen. Furthermore, the authors’ studies in 
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it will be interesting to learn whether 
CD44-dependent signals can influ-
ence the localization of cells to other 
damaged tissues and why the migrat-
ing MSCs do not get trapped in other 
HA-rich neighborhoods en route. It is 
known that complexity exists in the HA 
family of molecules and the proteins 
that attach to it — and that renal disease 
alters the structure and composition of 
the HA matrix, which in turn infl uences 
cell mobility (see, for example, Selbi 
et al.11). Perhaps particular molecular 
forms of HA generated by damage are 
better chemotactic agents, or synergy 
between various ‘damage signals’ makes 
the localization process dependent on 
CD44–HA interaction, but not directed 
by it?
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Figure 1 | Hyaluronan content in the kidney 
in a state of body hydration. (Reprinted from 
ref. 12.)
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Renal transplantation for ethnic 
minorities in Canada: Inequity in 
access and outcomes?
GVR Prasad1
Among Canadians starting dialysis, patients of East Asian and Indo 
Asian background are less likely than whites to receive a renal allograft. 
Although the reasons for such variation are complex, less living donation 
may contribute significantly. More studies are needed to confirm these 
differences and to evaluate strategies for improving live kidney donation 
rates in communities at risk for low transplantation rates.
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Universal health and immigration: The 
Canadian identity
Universal health care is a pillar of Can-
ada’s national pride. The first public 
hospital insurance plan was created in 
the province of Saskatchewan in 1947, 
and this was eventually followed by a 
series of federal government acts cul-
minating in the Canada Health Act of 
1984. Principles of health-care delivery 
in Canada include public administra-
tion, comprehensiveness, universality, 
portability, and accessibility. All legal 
residents, including Canadian citizens 
and landed immigrants, are eligible to 
receive defined health-care benefits 
under this system, largely sustained by 
governmental revenue.
Another fundamentally defi ning Cana-
dian characteristic is the encouragement 
of immigration. Canada’s economic suc-
cess attracts and is also sustained by 
immigration from far and wide. Canada 
has the highest percentage population 
growth rate from immigration among 
the G8 nations. Th ere is large represen-
tation from East Asia and Indo Asia, 
regions that together contribute about 
one-half of the world’s human popula-
tion. Is it possible that in a country with 
an enviable health-care system, ethnicity 
can infl uence rates of kidney transplanta-
tion and its consequent success?
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